SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-003390
Filing Date
2018-02-27
Accepted
2018-02-27 07:22:07
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atra-10k_20171231.htm 10-K 3351016
2 EX-21.1 atra-ex211_8.htm EX-21.1 7239
3 EX-23.1 atra-ex231_10.htm EX-23.1 2261
4 EX-31.1 atra-ex311_6.htm EX-31.1 16198
5 EX-31.2 atra-ex312_9.htm EX-31.2 16212
6 EX-32.1 atra-ex321_7.htm EX-32.1 8922
7 GRAPHIC g2018022702432596517948.jpg GRAPHIC 55493
8 GRAPHIC g2018022702433677517949.jpg GRAPHIC 23260
  Complete submission text file 0001564590-18-003390.txt   9547912

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT atra-20171231.xml EX-101.INS 1862808
10 XBRL TAXONOMY EXTENSION SCHEMA atra-20171231.xsd EX-101.SCH 53135
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20171231_cal.xml EX-101.CAL 62626
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20171231_def.xml EX-101.DEF 201338
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20171231_lab.xml EX-101.LAB 478180
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20171231_pre.xml EX-101.PRE 353725
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36548 | Film No.: 18642920
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences